Food News and Research

RSS

Monarch Medical Technologies gets FDA clearance for new glucose management solution

Monarch Medical Technologies, the pioneer and leader in mitigating risk associated with drugs and processes of concern in hospitalized patients, today announced the U.S. Food and Drug Administration clearance of its new glucose management solution, EndoTool IV.

28 Apr 2014

Forest Laboratories enters into definitive agreement to acquire Furiex

Forest Laboratories, Inc. nd Furiex Pharmaceuticals, Inc. today announced that Forest has entered into a definitive agreement to acquire Furiex, a drug development collaboration company, for $95 per share, or approximately $1.1 billion in cash, and up to $30 per share (approximately $360 million in aggregate) in a Contingent Value Right (CVR) that may be payable based on the status of eluxadoline, Furiex's lead product, as a controlled drug following approval.

28 Apr 2014

Mylan challenges FDA's decision regarding generic drug marketing exclusivity on Celecoxib Capsules

Mylan Inc. today announced that it has filed suit against the U.S. Food and Drug Administration, challenging the agency's decision regarding generic drug marketing exclusivity on Celecoxib Capsules, the generic version of Pfizer's Celebrex.

26 Apr 2014

Highlights from April 2014 issue of Mayo Clinic Health Letter

Here are highlights from the April issue of Mayo Clinic Health Letter.

26 Apr 2014

FDA approves new HPV cervical cancer test

The first human papillomavirus DNA test to screen women for cervical cancer was approved Thursday by the U.S. Food and Drug Administration. The stand-alone test can be used to assess whether women need to undergo additional testing and their risk of developing cervical cancer in the future (Rice, 4/24).

26 Apr 2014

Professor wins 2014 Outstanding Scientific Achievement Award from American Diabetes Association

Dr. Joel Elmquist, Director of the Center for Hypothalamic Research at UT Southwestern Medical Center, has been awarded the American Diabetes Association's Outstanding Scientific Achievement Award, the organization's top honor for an early-career scientist.

26 Apr 2014

FDA proposes new regulations for tobacco products

The American Thoracic Society applauds the Food and Drug Administration for moving forward with proposed rules to regulate all tobacco products, including e-cigarettes and cigars. This long awaited proposed rule is an important next step toward reducing the death and disease caused by tobacco use in the United States.

26 Apr 2014

Nitrogen Pollution, Climate And Land Use: Why What We Eat Matters

A new report quantifies for the first time how much our food choices affect pollutant nitrogen emissions, climate change and land-use across Europe.

26 Apr 2014

Blend of soy-dairy proteins may prolong muscle building after resistance exercise, says study

A new study published online in the Journal of Applied Physiology shows additional benefits of consuming a blend of soy and dairy proteins after resistance exercise for building muscle mass.

26 Apr 2014

CrossBay Medical gets FDA clearance for SonoSure Sonohysterography and Endometrial Sampling Device

CrossBay Medical, Inc., today announced the United States Food and Drug Administration clearance of its product, the SonoSure Sonohysterography and Endometrial Sampling Device. The device has also received Health Canada clearance and the CE mark. The SonoSure is indicated for use to access the uterine cavity for saline infusion sonohysterography and to obtain endometrial biopsy, if indicated, utilizing the same device.

26 Apr 2014

FDA proposes rule to include e-cigarettes under its tobacco authority

The U.S. Food and Drug Administration (FDA) has recently proposed a new rule to regulate additional tobacco products as part of its implementation of the 2009 Family Smoking Prevention and Tobacco Control Act.

25 Apr 2014

Alimera Sciences inks Loan and Security Agreement with Hercules Technology Growth Capital

Alimera Sciences, Inc., a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, announced today that its United Kingdom subsidiary, Alimera Sciences Limited, has entered into a Loan and Security Agreement with Hercules Technology Growth Capital, Inc. for a term loan in the principal amount of up to $35 million.

25 Apr 2014

First Edition: April 25, 2014

Today's headlines include reports about a recommendation that Oregon switch its troubled health exchange from a state-run marketplace to healthcare.gov.

25 Apr 2014

Use of frozen stool for fecal transplant successfully treats C. difficile infection

Using frozen stool from healthy, unrelated donors was safe and effective in treating patients with serious, relapsing diarrhea caused by Clostridium difficile, according to a new pilot study published in Clinical Infectious Diseases and available online.

25 Apr 2014

FDA grants marketing approval to GlaxoSmithKline's diabetes drug based on Novozymes' Veltis technology

The US Food and Drug Administration has granted marketing approval to GlaxoSmithKline's new type 2 diabetes drug, branded Tanzeum in the US and Eperzan in Europe, which uses Novozymes' Veltis technology to achieve an extended half-life that means patients are only required to inject their medication once a week.

25 Apr 2014

State highlights: Ohio hospital merger struck down; Okla. abortion drug use limited; Calif. exchange and felons

A federal appeals court on Tuesday ordered a major health system in northwest Ohio to unwind its merger with a local hospital on antitrust grounds. The unanimous decision by a three-judge panel of the Sixth U.S. Circuit Court of Appeals in Cincinnati comes amid growing concerns about hospital mergers and their effect on prices against the backdrop of America's health care upheaval (Gershman, 4/22).

25 Apr 2014

Food News and Research

Monarch Medical Technologies gets FDA clearance for new glucose management solution

Forest Laboratories enters into definitive agreement to acquire Furiex

Mylan challenges FDA's decision regarding generic drug marketing exclusivity on Celecoxib Capsules

Highlights from April 2014 issue of Mayo Clinic Health Letter

FDA approves new HPV cervical cancer test

Professor wins 2014 Outstanding Scientific Achievement Award from American Diabetes Association

FDA proposes new regulations for tobacco products

Nitrogen Pollution, Climate And Land Use: Why What We Eat Matters

Blend of soy-dairy proteins may prolong muscle building after resistance exercise, says study

CrossBay Medical gets FDA clearance for SonoSure Sonohysterography and Endometrial Sampling Device

FDA proposes rule to include e-cigarettes under its tobacco authority

Alimera Sciences inks Loan and Security Agreement with Hercules Technology Growth Capital

First Edition: April 25, 2014

Use of frozen stool for fecal transplant successfully treats C. difficile infection

FDA grants marketing approval to GlaxoSmithKline's diabetes drug based on Novozymes' Veltis technology

State highlights: Ohio hospital merger struck down; Okla. abortion drug use limited; Calif. exchange and felons

Biomedical engineer develops highly innovative technology to make blood transfusions safer

FSA project to map occurrence of norovirus in food premises

Enhanced recovery approach used for colorectal surgery cut hospital stays

Aetna raises earnings outlook

The future is bioengineered: Synthetic biology and global sustainability eBook

Managing vibration in IVF laboratories

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Latest News